Clinical Trial Update: BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing BST-DERMON to standard of care for diabetic foot ulcers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• BST-DERMON

Snippet

Sponsor: BioSyntech Canada Inc. | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: TERMINATED